Cargando…
High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model
Anticancer potential of metformin has been extensively studied. However, its anticancer clinical use remains yet to be approved since sufficient concentration on target organs could not be achieved via conventional administration. To overcome this drawback, we aim to examine the efficiency of novel...
Autores principales: | Peng, Mei, Su, Qiongli, Zeng, Qing, Li, Le, Liu, Zhihong, Xue, Lei, Cheng, Yan, Huang, Yanjun, Tao, Ting, Lv, Hongwei, Li, Xiaohui, Tao, Xiaojun, Guo, Peng, Chen, Alex F., Yang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891029/ https://www.ncbi.nlm.nih.gov/pubmed/26802022 http://dx.doi.org/10.18632/oncotarget.6933 |
Ejemplares similares
-
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016) -
Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration
por: Zhang, Xingjian, et al.
Publicado: (2023) -
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
por: Huang, Yanjun, et al.
Publicado: (2018) -
Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
por: Su, Qiongli, et al.
Publicado: (2018) -
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013)